| Literature DB >> 29854026 |
Esther Paredes-Sánchez1, José María Montiel-Company1, José Enrique Iranzo-Cortés1, Teresa Almerich-Torres1, Carlos Bellot-Arcís1, José Manuel Almerich-Silla1.
Abstract
The objective was to collect the available evidence on oxidative stress marker measurements in periodontal patients, focusing specifically on 8-hydroxy-2'-deoxyguanosine (8-OHdG) as a salivary marker of periodontal disease, and to perform meta-analyses to calculate differences in concentration compared to healthy persons. A systematic search in PubMed, Cochrane Library, Embase, and Scopus identified 81 articles. Of these, 38 were duplicates. After reading the abstracts of the remaining 43, 42 were selected for full-text assessment. Finally, 17 articles were included in the qualitative synthesis. Those excluded were of low quality, did not answer the research question, or did not meet the inclusion and exclusion criteria. Of the 17 in the qualitative synthesis, 9 were included in the meta-analysis. The 9 studies in the meta-analysis were combined in a random effects model. Their heterogeneity was high (Q = 3982.02, p < 0.001, I2 = 99.8%). The difference in mean 8-OHdG concentration in saliva between periodontal and healthy subjects was estimated at 2.11 ng/ml (95% CI 1.23-2.98). The different saliva collection methods (stimulated/unstimulated) did not explain the heterogeneity. The 8-OHdG levels in saliva of periodontal patients were almost double to those of healthy patients: 8-OHdG is clearly a powerful periodontal disease marker.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29854026 PMCID: PMC5954896 DOI: 10.1155/2018/7916578
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.434
Figure 1Flow chart.
Quality of the studies according to the Newcastle-Ottawa quality assessment scale.
| Study | Selection | Comparability | Exposure | Total stars |
|---|---|---|---|---|
| Takane et al. 2002 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Sawamoto et al. 2005 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Takane et al. 2005 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Totan et al. 2006 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Greabu et al. 2006 [ | ∗∗∗ | ∗ | ∗∗ | 6 |
| Badea et al. 2010 [ | ∗∗∗∗ | ∗ | ∗∗ | 5 |
| Sezer et al. 2012 [ | ∗∗∗∗ | ∗∗ | ∗∗∗ | 9 |
| Komatsu et al. 2013 [ | ∗∗∗ | ∗ | ∗∗∗ | 7 |
| Dede et al. 2013 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Pendyala et al. 2013 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Miricescu et al. 2014 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Hernández-Monjaraz et al. 2014 [ | ∗∗ | ∗ | ∗∗ | 5 |
| Baňasová et al. 2014 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Baltacioglu et al. 2014 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Trivedi et al. 2014 [ | ∗∗∗∗ | ∗ | ∗∗∗ | 8 |
| Almerich-Silla et al. 2015 [ | ∗∗∗∗ | ∗∗ | ∗∗∗ | 9 |
| Zamora-Perez et al. 2015 [ | ∗∗∗∗ | ∗∗ | ∗∗∗ | 9 |
Qualitative analysis.
| Study author/year [reference] | Study type |
| Variables | Case criteria (PD) | Saliva sample | Results | Significant difference | NOS |
|---|---|---|---|---|---|---|---|---|
| Takane et al. 2002 [ | CC | PD: 78; 21–69 | 8-OHdG | At least 2 sites with PP > 4 mm | S | PD 4.28 ± 0.10 | Yes | 8/10 |
| Sawamoto et al. 2005 [ | CC | PD:29; 36–68 | 8-OHdG | At least 2 sites with PP > 4 mm | S | PD 4.36 ± 0.18 | Yes | 8/10 |
| Takane et al. 2005 [ | CC | PD: 18; 21–67 | 8-OHdG | At least 2 sites with PP > 4 mm | S | PD 2.35 ± 0.18 | Yes | 8/10 |
| Totan et al. 2006 [ | CC | PD: 25; 25–55 | AST | PP > 5 mm, LA > 40% | NS | — | — | 8/10 |
| Greabu et al. 2006 [ | CC | PD:30; 16–82 | Uric acid | Not specified | NS | — | — | 6/10 |
| Badea et al. 2010 [ | CC | PD: 85; — | 8-OHdG | Not specified | — | PD 3.00–7.50 | Yes | 5/10 |
| Sezer et al. 2012 [ | CC | PD: 20; 29–58 | 8-OHdG | At least 4 sites with PP > 5 mm | S | PD 3.13 ± 0.22 | Yes | 9/10 |
| Komatsu et al. 2013 [ | CC | PD: 21; 44.7 ± 8.8 | 8-OHdG | PDT sensor probe | NS | PD 3.30 ± 1.44 | Yes | 7/10 |
| Dede et al. 2013 [ | CC | PD: 24; 30–55 | 8-OHdG | At least 2 sites with PP > 5 mm and LB > 30% | NS | PD 0.61 ± 0.14 | No | 8/10 |
| Pendyala et al. 2013 [ | CC | PD: 30; 40–65 | TAC | 2 or more sites with PP > 4 mm or LA > 4 mm with bleeding | NS | — | — | 8/10 |
| Miricescu et al. 2014 [ | CC | PD: 20 | 8-OHdG | At least 6 sites with PP > 4 mm, LB > 30% | NS | PD 6.78 ± 1.80 | No | 8/10 |
| Hernández-Monjaraz et al. 2014 [ | CSt | PD: 23 | SOD | Not specified | — | — | — | 5/10 |
| Baňasová et al. 2014 [ | CC | PD: 23; 43 ± 7.6 | TBARS | At least 16 sites with PP > 4 mm in 2 different quadrants | S | — | — | 8/10 |
| Baltacioglu et al. 2014 [ | CC | PD: 68; 26–42 | MDA | Multiple sites with PP > 5 mm, LB > 30% and LA > 5 mm. | NS | — | — | 8/10 |
| Trivedi et al. 2014 [ | CC | PD: 30; 20–65 | SOD | At least 2 sites with PP > 4 mm or LA > 4 mm | NS | — | — | 8/10 |
| Almerich-Silla et al. 2015 [ | CC | PD: 33; 41–45 | 8-OHdG | At least 4 sites with PP > 5 mm and LA > 2 mm | NS | PD 5.54 (4.96–6.12); | Yes | 9/10 |
| Zamora-Perez et al. 2015 [ | CC | PD: 100; 39.03 | 8-OHdG | At least 6 sites with PP >6 mm and LA >5 mm | NS | PD 11.13 ± 1.91 | — | 9/10 |
N: sample size; CC: case-control; CS: cross-sectional; PD: periodontal disease; G: gingivitis; C: control group; PP: periodontal pocket; LA: loss of attachment; LB: level of bleeding; S: stimulated; NS: not stimulated.
Figure 2Forest plot of mean 8-OHdG concentration in healthy subjects.
Figure 3Forest plot of the differences in mean 8-OHdG concentration between periodontal disease patients and healthy controls.
Figure 4Forest plot of the differences in mean 8-OHdG concentration between periodontal disease patients and healthy controls using the “one study removed” method.
Figure 5Forest plot of the differences in mean 8-OHdG concentration between periodontal disease patients and healthy controls with unstimulated saliva sample collection.
Figure 6Forest plot of the differences in mean 8-OHdG concentration between periodontal disease patients and healthy controls with stimulated saliva sample collection.
Figure 7Funnel plot.